CERS
Price
$1.48
Change
-$0.03 (-1.99%)
Updated
Sep 26, 01:00 PM (EDT)
Capitalization
289.47M
34 days until earnings call
SAFLY
Price
$3.39
Change
+$1.10 (+48.03%)
Updated
Aug 21 closing price
Capitalization
745.19M
Interact to see
Advertisement

CERS vs SAFLY

Header iconCERS vs SAFLY Comparison
Open Charts CERS vs SAFLYBanner chart's image
Cerus
Price$1.48
Change-$0.03 (-1.99%)
Volume$1.85K
Capitalization289.47M
Safilo Group Spa
Price$3.39
Change+$1.10 (+48.03%)
Volume$121
Capitalization745.19M
CERS vs SAFLY Comparison Chart in %
Loading...
CERS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SAFLY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CERS vs. SAFLY commentary
Sep 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CERS is a StrongBuy and SAFLY is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 26, 2025
Stock price -- (CERS: $1.51 vs. SAFLY: $3.39)
Brand notoriety: CERS and SAFLY are both not notable
CERS represents the Medical/Nursing Services, while SAFLY is part of the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: CERS: 107% vs. SAFLY: 100%
Market capitalization -- CERS: $289.47M vs. SAFLY: $745.19M
CERS [@Medical/Nursing Services] is valued at $289.47M. SAFLY’s [@Pharmaceuticals: Other] market capitalization is $745.19M. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $232.02B to $0. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $157.06B to $0. The average market capitalization across the [@Medical/Nursing Services] industry is $5.49B. The average market capitalization across the [@Pharmaceuticals: Other] industry is $10.92B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CERS’s FA Score shows that 0 FA rating(s) are green whileSAFLY’s FA Score has 0 green FA rating(s).

  • CERS’s FA Score: 0 green, 5 red.
  • SAFLY’s FA Score: 0 green, 5 red.
According to our system of comparison, SAFLY is a better buy in the long-term than CERS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CERS’s TA Score shows that 6 TA indicator(s) are bullish while SAFLY’s TA Score has 2 bullish TA indicator(s).

  • CERS’s TA Score: 6 bullish, 4 bearish.
  • SAFLY’s TA Score: 2 bullish, 1 bearish.
According to our system of comparison, CERS is a better buy in the short-term than SAFLY.

Price Growth

CERS (@Medical/Nursing Services) experienced а +16.15% price change this week, while SAFLY (@Pharmaceuticals: Other) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -1.55%. For the same industry, the average monthly price growth was +3.35%, and the average quarterly price growth was +9.85%.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -2.51%. For the same industry, the average monthly price growth was -3.36%, and the average quarterly price growth was +8.17%.

Reported Earning Dates

CERS is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Medical/Nursing Services (-1.55% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

@Pharmaceuticals: Other (-2.51% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SAFLY($745M) has a higher market cap than CERS($289M). SAFLY YTD gains are higher at: 52.018 vs. CERS (-1.948). SAFLY has higher annual earnings (EBITDA): 107M vs. CERS (-8.62M). CERS has more cash in the bank: 78M vs. SAFLY (72.6M). CERS has less debt than SAFLY: CERS (98.9M) vs SAFLY (115M). SAFLY has higher revenues than CERS: SAFLY (999M) vs CERS (193M).
CERSSAFLYCERS / SAFLY
Capitalization289M745M39%
EBITDA-8.62M107M-8%
Gain YTD-1.94852.018-4%
P/E RatioN/A12.81-
Revenue193M999M19%
Total Cash78M72.6M107%
Total Debt98.9M115M86%
FUNDAMENTALS RATINGS
CERS vs SAFLY: Fundamental Ratings
CERS
SAFLY
OUTLOOK RATING
1..100
2137
VALUATION
overvalued / fair valued / undervalued
1..100
37
Fair valued
65
Fair valued
PROFIT vs RISK RATING
1..100
10045
SMR RATING
1..100
9770
PRICE GROWTH RATING
1..100
4740
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
5065

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CERS's Valuation (37) in the Medical Specialties industry is in the same range as SAFLY (65) in the null industry. This means that CERS’s stock grew similarly to SAFLY’s over the last 12 months.

SAFLY's Profit vs Risk Rating (45) in the null industry is somewhat better than the same rating for CERS (100) in the Medical Specialties industry. This means that SAFLY’s stock grew somewhat faster than CERS’s over the last 12 months.

SAFLY's SMR Rating (70) in the null industry is in the same range as CERS (97) in the Medical Specialties industry. This means that SAFLY’s stock grew similarly to CERS’s over the last 12 months.

SAFLY's Price Growth Rating (40) in the null industry is in the same range as CERS (47) in the Medical Specialties industry. This means that SAFLY’s stock grew similarly to CERS’s over the last 12 months.

SAFLY's P/E Growth Rating (100) in the null industry is in the same range as CERS (100) in the Medical Specialties industry. This means that SAFLY’s stock grew similarly to CERS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CERSSAFLY
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
88%
Bullish Trend 1 day ago
25%
Momentum
ODDS (%)
Bullish Trend 1 day ago
69%
N/A
MACD
ODDS (%)
Bullish Trend 1 day ago
75%
Bearish Trend 1 day ago
20%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
74%
Bullish Trend 1 day ago
13%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
75%
Bullish Trend 1 day ago
14%
Advances
ODDS (%)
Bullish Trend 4 days ago
75%
N/A
Declines
ODDS (%)
Bearish Trend 1 day ago
85%
N/A
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
N/A
Aroon
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 1 day ago
15%
View a ticker or compare two or three
Interact to see
Advertisement
CERS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SAFLY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JCVCX24.47N/A
N/A
JHancock Classic Value C
MSFHX20.12N/A
N/A
MFS Total Return R3
GCIFX15.49N/A
N/A
Green Century MSCI Intl Indx Instl
RYVAX189.90N/A
N/A
Rydex Energy Services H
TEMLX10.02N/A
N/A
Nuveen Emerging Markets Eq R6

CERS and

Correlation & Price change

A.I.dvisor indicates that over the last year, CERS has been loosely correlated with ITGR. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if CERS jumps, then ITGR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CERS
1D Price
Change %
CERS100%
-1.95%
ITGR - CERS
52%
Loosely correlated
-1.17%
LAB - CERS
47%
Loosely correlated
-1.53%
ICUI - CERS
46%
Loosely correlated
-6.54%
UTMD - CERS
45%
Loosely correlated
-0.68%
BLFS - CERS
45%
Loosely correlated
+0.29%
More

SAFLY and

Correlation & Price change

A.I.dvisor indicates that over the last year, SAFLY has been loosely correlated with BIOQ. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if SAFLY jumps, then BIOQ could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SAFLY
1D Price
Change %
SAFLY100%
N/A
BIOQ - SAFLY
34%
Loosely correlated
N/A
CNVVF - SAFLY
32%
Poorly correlated
N/A
TCHBF - SAFLY
29%
Poorly correlated
N/A
LZAGY - SAFLY
28%
Poorly correlated
-1.16%
CERS - SAFLY
25%
Poorly correlated
-1.95%
More